Pamela Goldberg is globally recognized leader in medical technology innovation, leading strategy to affect change for industry and regulators. Her focus on collaboration and driving change have been instrumental in making progress for the medical device industry in partnership with the FDA, patient advocacy groups and clinical sites. During her time at MDIC, she has led its growth with RWE, clinical trial science, digital technologies, and health economics.
Goldberg was previously CEO of the Massachusetts Technology Collaborative. She worked closely with industry, academic and government leaders to advance technology-based solutions that improved the health care system, expanded high-speed Internet access and strengthened the growth and development of the state’s technology sector with specific focus on innovation, digital health, data analytics, robotics, and cybersecurity.
Goldberg is advisor and board member to several technology startups and earlier in her career launched three start-up ventures. She received her BA from Tufts University and MBA from Stanford University.
